Related references
Note: Only part of the references are listed.Molecular mechanisms underlying stress response and adaptation
Shuang Sun et al.
THORACIC CANCER (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
DNA-binding landscape of IRF3, IRF5 and IRF7 dimers: implications for dimer-specific gene regulation
Kellen K. Andrilenas et al.
NUCLEIC ACIDS RESEARCH (2018)
Impact of oncogenic pathways on evasion of antitumour immune responses
Stefani Spranger et al.
NATURE REVIEWS CANCER (2018)
Improving immune-vascular crosstalk for cancer immunotherapy
Yuhui Huang et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Lin Tian et al.
NATURE (2017)
UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer
Kenji Imai et al.
ONCOLOGY LETTERS (2017)
Estimation of immune cell content in tumour tissue using single-cell RNA-seq data
Max Schelker et al.
NATURE COMMUNICATIONS (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Uncoupling protein 2 in the glial response to stress: implications for neuroprotection
Daniel T. Hass et al.
NEURAL REGENERATION RESEARCH (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations
Katrina Meeth et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma (vol 15, pg 857, 2016)
Marios Giannakis et al.
CELL REPORTS (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay et al.
CELL (2015)
UCP2 inhibition sensitizes breast cancer cells to therapeutic agents by increasing oxidative stress
Daniel Gabriel Pons et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment
Thomas F. Gajewski
SEMINARS IN ONCOLOGY (2015)
Immune-Based Antitumor Effects of BRAF Inhibitors Rely on Signaling by CD40L and IFNγ
Ping-Chih Ho et al.
CANCER RESEARCH (2014)
Mitochondrial Retrograde Signaling Mediated by UCP2 Inhibits Cancer Cell Proliferation and Tumorigenesis
Pauline Esteves et al.
CANCER RESEARCH (2014)
In vivo evidence for an instructive role of fms-like tyrosine kinase-3 (FLT3) ligand in hematopoietic development
Panagiotis Tsapogas et al.
HAEMATOLOGICA (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer
Michael L. Gatza et al.
NATURE GENETICS (2014)
IKKβ is an IRF5 kinase that instigates inflammation
Junyao Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Secondary T cell-T cell synaptic interactions drive the differentiation of protective CD8+ T cells
Audrey Gerard et al.
NATURE IMMUNOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine
Elisa Dalla Pozza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
IRF5 gene polymorphisms in melanoma
Lorenzo Uccellini et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
A Novel Intronic Peroxisome Proliferator-activated Receptor γ Enhancer in the Uncoupling Protein (UCP) 3 Gene as a Regulator of Both UCP2 and-3 Expression in Adipocytes
Anne Bugge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Discovering causal signaling pathways through gene-expression patterns
Jignesh R. Parikh et al.
NUCLEIC ACIDS RESEARCH (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing
Frederic Bouillaud
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells
Zoltan Derdak et al.
CANCER RESEARCH (2008)
Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization
Claire Pecqueur et al.
FASEB JOURNAL (2008)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
PPARs in the Control of Uncoupling Proteins Gene Expression
Francesc Villarroya et al.
PPAR RESEARCH (2007)
Leu-574 of human HIF-1a is a molecular determinant of prolyl hydroxylation
Y Kageyama et al.
FASEB JOURNAL (2004)
Expression of uncoupling protein-2 in human colon cancer
M Horimoto et al.
CLINICAL CANCER RESEARCH (2004)
Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury
I Bechmann et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Share Paper
